Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.

There was no significant difference in remission rates between ILAR subtypes of JIA at 6 or 12 months ( P = 0.71 and P = 0.055, respectively), although more patients with ERA and JPsA achieved remission at 12 months, with a trend towards significance.

also in 2,760 other papers